VEGF-A165b reduces vascular dysfunction in the diabetic retina

被引:0
|
作者
Ved, Nikita [1 ,2 ]
Hulse, Richard [2 ]
Bestall, Samuel [2 ,3 ]
Donaldson, Lucy [3 ]
Bainbridge, James W. B. [1 ]
Bates, David [2 ]
机构
[1] UCL, Inst Ophthalmol, Genet, London, England
[2] Univ Nottingham, Queens Med Ctr, Tumour & Vasc Res Labs, Nottingham NG7 2RD, England
[3] Queens Med Ctr, Sch Life Sci, Nottingham NG7 2UH, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
926
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Implication of anti-angiogenic VEGF-A165b in angiogenesis and systolic function after reperfused myocardial infarction
    Marcos Garces, V
    Rios-Navarro, C.
    Hueso, L.
    Diaz, A.
    Bonanad, C.
    Ruiz-Sauri, A.
    Sanz, M. J.
    Chorro, F. J.
    Piqueras, L.
    Bodi, V
    EUROPEAN HEART JOURNAL, 2020, 41 : 3645 - 3645
  • [22] WNT5A regulates adipose tissue angiogenesis via antiangiogenic VEGF-A165b in obese humans
    Karki, Shakun
    Ngo, Doan T. M.
    Farb, Melissa G.
    Park, Song Young
    Saggese, Samantha M.
    Hamburg, Naomi M.
    Carmine, Brian
    Hess, Donald T.
    Walsh, Kenneth
    Gokce, Noyan
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 313 (01): : H200 - H206
  • [23] Vascular endothelial growth factor (VEGF165b) is significantly downregulated in the plasma of diabetic patients with proliferative diabetic retinopathy
    Perrin, RM
    Turner, SJ
    Qiu, Y
    Harper, SJ
    Churchill, AJ
    Bates, DO
    FASEB JOURNAL, 2004, 18 (04): : A258 - A258
  • [24] Overexpression of VEGF165b in Podocytes Reduces Glomerular Permeability
    Qiu, Yan
    Ferguson, Joanne
    Oltean, Sebastian
    Neal, Chris R.
    Kaura, Amit
    Bevan, Heather
    Wood, Emma
    Sage, Leslie M.
    Lanati, Silvia
    Nowak, Dawid G.
    Salmon, Andy H. J.
    Bates, David
    Harper, Steve J.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (09): : 1498 - 1509
  • [25] VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment
    Karsten, Maria Margarete
    Beck, Maximilian Heinz
    Rademacher, Angela
    Knabl, Julia
    Blohmer, Jens-Uwe
    Jueckstock, Julia
    Radosa, Julia Caroline
    Jank, Paul
    Rack, Brigitte
    Janni, Wolfgang
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] A novel therapeutic intervention, VEGF165b for Diabetic Neuropathy
    Hulse, R. P.
    Bates, D. O.
    Donaldson, L. F.
    DIABETIC MEDICINE, 2013, 30 : 67 - 67
  • [27] VEGF-A165b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF-A splice isoforms from the kidney
    Stevens, Megan
    Neal, Christopher R.
    Salmon, Andrew H. J.
    Bates, David O.
    Harper, Steven J.
    Oltean, Sebastian
    JOURNAL OF PHYSIOLOGY-LONDON, 2017, 595 (19): : 6281 - 6298
  • [28] VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment
    Maria Margarete Karsten
    Maximilian Heinz Beck
    Angela Rademacher
    Julia Knabl
    Jens-Uwe Blohmer
    Julia Jückstock
    Julia Caroline Radosa
    Paul Jank
    Brigitte Rack
    Wolfgang Janni
    Scientific Reports, 10
  • [29] Vascular endothelial growth factor (VEGF165) gene transfer for diabetic neuropathy
    Ropper, AH
    Pieczek, A
    Visnaw, K
    Kershen, J
    Weinberg, D
    Gorson, K
    Huang, SG
    Losordo, D
    NEUROLOGY, 2005, 64 (06) : A6 - A6
  • [30] Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant
    Wimberger, Pauline
    Gerber, Mara Julia
    Pfisterer, Jacobus
    Erdmann, Kati
    Fuessel, Susanne
    Link, Theresa
    du Bois, Andreas
    Kommoss, Stefan
    Heitz, Florian
    Sehouli, Jalid
    Kimmig, Rainer
    de Gregorio, Nikolaus
    Schmalfeldt, Barbara
    Park-Simon, Tjoung-Won
    Baumann, Klaus
    Hilpert, Felix
    Grube, Marcel
    Schroder, Willibald
    Burges, Alexander
    Belau, Antje
    Harser, Lars
    Kuhlmann, Jan Dominik
    CLINICAL CANCER RESEARCH, 2022, 28 (21) : 4660 - 4668